Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation

Identification of targetable molecular changes is essential for selecting appropriate treatment in patients with advanced lung adenocarcinoma. Methods: In this study, a Sanger sequencing plus Fluorescence In Situ Hybridization (FISH) sequential approach was compared with a Next-Generation Sequencing...

Full description

Bibliographic Details
Main Author: Fernandes, Maria Gabriela O. (author)
Other Authors: Jacob, Maria (author), Martins, Natália (author), Moura, Conceição Souto (author), Guimarães, Susana (author), Pereira Reis, Joana (author), Justino, Ana (author), Pina, Maria João (author), Cirnes, Luís (author), Sousa, Catarina (author), Pinto, Josué (author), Marques, José Agostinho (author), Machado, José Carlos (author), Hespanhol, Venceslau (author), Costa, José Luis (author)
Format: article
Language:eng
Published: 2019
Subjects:
Lung cancer
molecular profiling
next-generation sequencing
argeted therapy
Online Access:http://hdl.handle.net/10400.22/14843
Country:Portugal
Oai:oai:recipp.ipp.pt:10400.22/14843

Internet

http://hdl.handle.net/10400.22/14843

Similar Items